[{"command":"add_css","data":[{"rel":"stylesheet","media":"all","href":"\/core\/modules\/views\/css\/views.module.css?suu4vb"}]},{"command":"insert","method":"replaceWith","selector":"#case-definition-glossary-wrapper","data":"\u003Cdiv id=\u0022case-definition-glossary-wrapper\u0022\u003E\u003Cdiv class=\u0022accordion-multilevel case-definition-a-z js-view-dom-id-c2259a6fe158928ce57123682805b68b2592d9e349dce0a076f66fa720ff2352\u0022\u003E\n \n \n \n\n \n \n \n\n \u003Cdiv class=\u0022views-view-grid horizontal cols-400000 clearfix\u0022\u003E\n \u003Cdiv class=\u0022case-definitions\u0022\u003E\n \u003Cdiv class=\u0022item-content\u0022\u003E\u003Cdiv\u003E\u003Cdiv\u003E\u003Cdiv class=\u0022wrap-field-data-table\u0022\u003E\n\u003Cdiv class=\u0022title-level-3 js-title-level-3\u0022\u003E\nInfantile Krabbe Disease\u003C\/div\u003E\n\u003Cdiv class=\u0022field-data-table-content\u0022\u003E\n\u003Ctable data-striping=\u00221\u0022\u003E\n \n \n \n \u003Ctbody\u003E\n \u003Ctr\u003E\n \u003C\/tr\u003E\n \u003C\/tbody\u003E\n \u003C\/table\u003E\n \u003C\/div\u003E\n\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\n \u003Cdiv class=\u0022item-content\u0022\u003E\u003Cdiv\u003E\u003Cdiv\u003E\u003Cdiv class=\u0022wrap-field-data-table\u0022\u003E\n\u003Cdiv class=\u0022title-level-3 js-title-level-3\u0022\u003E\nIsovaleric acidemia (IVA)\u003C\/div\u003E\n\u003Cdiv class=\u0022field-data-table-content\u0022\u003E\n\u003Ctable data-striping=\u00221\u0022\u003E\n \n \n \u003Cthead\u003E\n \u003Ctr\u003E\n \u003Cth class=\u0022classification\u0022\u003EClassification\u003C\/th\u003E\n \u003Cth class=\u0022urine-organic-acids\u0022\u003EUrine organic acids\u003C\/th\u003E\n \u003Cth class=\u0022plasma-acylcarnitines\u0022\u003EPlasma Acylcarnitines\u003C\/th\u003E\n \u003Cth class=\u0022mutation-analysis\u0022\u003EMutation analysis\u003C\/th\u003E\n \u003Cth class=\u0022enzyme-analysis\u0022\u003EEnzyme analysis\u003C\/th\u003E\n \u003C\/tr\u003E\n \u003C\/thead\u003E\n \n \u003Ctbody\u003E\n \u003Ctr\u003E\n \u003Ctd class=\u0022classification\u0022\u003EDefinite\u003C\/td\u003E\n \u003Ctd class=\u0022urine-organic-acids\u0022\u003EUntested or unknown\u003C\/td\u003E\n \u003Ctd class=\u0022plasma-acylcarnitines\u0022\u003EUntested or unknown\u003C\/td\u003E\n \u003Ctd class=\u0022mutation-analysis\u0022\u003E2 known disease causing variants in the same gene (Allele 1 - variant known to be disease causing and Allele 2 - variant known to be disease causing)\u003C\/td\u003E\n \u003Ctd class=\u0022enzyme-analysis\u0022\u003EUntested or unknown\u003C\/td\u003E\n \u003C\/tr\u003E\n \u003Ctr\u003E\n \u003Ctd class=\u0022classification\u0022\u003EDefinite\u003C\/td\u003E\n \u003Ctd class=\u0022urine-organic-acids\u0022\u003EUntested or unknown\u003C\/td\u003E\n \u003Ctd class=\u0022plasma-acylcarnitines\u0022\u003EUntested or unknown\u003C\/td\u003E\n \u003Ctd class=\u0022mutation-analysis\u0022\u003EUntested or unknown\u003C\/td\u003E\n \u003Ctd class=\u0022enzyme-analysis\u0022\u003EEnzyme activity on fibroblasts or WBCs consistent with disease\u003C\/td\u003E\n \u003C\/tr\u003E\n \u003Ctr\u003E\n \u003Ctd class=\u0022classification\u0022\u003EDefinite\u003C\/td\u003E\n \u003Ctd class=\u0022urine-organic-acids\u0022\u003EElevated - isovalerylglycine and - 3-OH Isovaleric\u003C\/td\u003E\n \u003Ctd class=\u0022plasma-acylcarnitines\u0022\u003EElevated C5\u003C\/td\u003E\n \u003Ctd class=\u0022mutation-analysis\u0022\u003EUntested or unknown\u003C\/td\u003E\n \u003Ctd class=\u0022enzyme-analysis\u0022\u003EUntested or unknown\u003C\/td\u003E\n \u003C\/tr\u003E\n \u003Ctr\u003E\n \u003Ctd class=\u0022classification\u0022\u003EDefinite\u003C\/td\u003E\n \u003Ctd class=\u0022urine-organic-acids\u0022\u003EElevated Isovalerylglycine\u003C\/td\u003E\n \u003Ctd class=\u0022plasma-acylcarnitines\u0022\u003EElevated C5\u003C\/td\u003E\n \u003Ctd class=\u0022mutation-analysis\u0022\u003E2 variants of uncertain significance in the same gene - predicted to be pathogenic [Allele 1 - variant of unknown significance (predicted to be pathogenic) and Allele 2 - variant of unknown significance (predicted to be pathogenic)]\u003C\/td\u003E\n \u003Ctd class=\u0022enzyme-analysis\u0022\u003EUntested or unknown\u003C\/td\u003E\n \u003C\/tr\u003E\n \u003Ctr\u003E\n \u003Ctd class=\u0022classification\u0022\u003EPossible\u003C\/td\u003E\n \u003Ctd class=\u0022urine-organic-acids\u0022\u003EElevated Isovalerylglycine\u003C\/td\u003E\n \u003Ctd class=\u0022plasma-acylcarnitines\u0022\u003EElevated C5\u003C\/td\u003E\n \u003Ctd class=\u0022mutation-analysis\u0022\u003EUntested or unknown\u003C\/td\u003E\n \u003Ctd class=\u0022enzyme-analysis\u0022\u003EUntested or unknown\u003C\/td\u003E\n \u003C\/tr\u003E\n \u003Ctr\u003E\n \u003Ctd class=\u0022classification\u0022\u003EPossible\u003C\/td\u003E\n \u003Ctd class=\u0022urine-organic-acids\u0022\u003EElevated Isovalerylglycine\u003C\/td\u003E\n \u003Ctd class=\u0022plasma-acylcarnitines\u0022\u003EElevated C5\u003C\/td\u003E\n \u003Ctd class=\u0022mutation-analysis\u0022\u003E1 known disease causing variant (Allele 1 - variant known to be disease causing)\u003C\/td\u003E\n \u003Ctd class=\u0022enzyme-analysis\u0022\u003EUntested or unknown\u003C\/td\u003E\n \u003C\/tr\u003E\n \u003Ctr\u003E\n \u003Ctd class=\u0022classification\u0022\u003EPossible\u003C\/td\u003E\n \u003Ctd class=\u0022urine-organic-acids\u0022\u003EElevated Isovalerylglycine\u003C\/td\u003E\n \u003Ctd class=\u0022plasma-acylcarnitines\u0022\u003EElevated C5\u003C\/td\u003E\n \u003Ctd class=\u0022mutation-analysis\u0022\u003E2 variants of uncertain significance in the same gene (Allele 1 - variant of unknown significance and Allele 2 - variant of unknown significance)\u003C\/td\u003E\n \u003Ctd class=\u0022enzyme-analysis\u0022\u003EUntested or unknown\u003C\/td\u003E\n \u003C\/tr\u003E\n \u003C\/tbody\u003E\n \u003C\/table\u003E\n \u003C\/div\u003E\n\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n\n \n \n \n \n\u003C\/div\u003E\n\u003C\/div\u003E","settings":null}]